Valbiotis SA (ALVAL.PA)

EUR 1.0

(-0.38%)

Total Liabilities Summary of Valbiotis SA

  • Valbiotis SA's latest annual total liabilities in 2023 was 13.7 Million EUR , down -1.08% from previous year.
  • Valbiotis SA's latest quarterly total liabilities in 2023 FY was 13.7 Million EUR , down -1.08% from previous quarter.
  • Valbiotis SA reported annual total liabilities of 13.85 Million EUR in 2022, down -2.72% from previous year.
  • Valbiotis SA reported annual total liabilities of 14.24 Million EUR in 2021, up 2.29% from previous year.
  • Valbiotis SA reported quarterly total liabilities of 13.7 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Valbiotis SA reported quarterly total liabilities of 13.7 Million EUR for 2023 FY, down -1.08% from previous quarter.

Annual Total Liabilities Chart of Valbiotis SA (2023 - 2015)

Historical Annual Total Liabilities of Valbiotis SA (2023 - 2015)

Year Total Liabilities Total Liabilities Growth
2023 13.7 Million EUR -1.08%
2022 13.85 Million EUR -2.72%
2021 14.24 Million EUR 2.29%
2020 13.92 Million EUR 104.63%
2019 6.8 Million EUR 51.35%
2018 4.49 Million EUR 76.15%
2017 2.55 Million EUR 103.43%
2016 1.25 Million EUR 16.31%
2015 1.07 Million EUR 0.0%

Peer Total Liabilities Comparison of Valbiotis SA

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -98.322%
ABIVAX Société Anonyme 131.05 Million EUR 89.54%
Adocia SA 31.87 Million EUR 56.988%
Aelis Farma SA 13.08 Million EUR -4.801%
Biophytis S.A. 15.84 Million EUR 13.509%
Advicenne S.A. 24.37 Million EUR 43.767%
genOway Société anonyme 14.45 Million EUR 5.197%
IntegraGen SA 5.97 Million EUR -129.239%
Medesis Pharma S.A. 6.42 Million EUR -113.315%
Neovacs S.A. 3.71 Million EUR -269.276%
NFL Biosciences SA 3.62 Million EUR -278.603%
Plant Advanced Technologies SA 6.78 Million EUR -102.113%
Quantum Genomics Société Anonyme 3.31 Million EUR -314.126%
Sensorion SA 13.22 Million EUR -3.634%
Theranexus Société Anonyme 5.01 Million EUR -173.275%
TME Pharma N.V. 2.78 Million EUR -392.208%
TheraVet SA 1.48 Million EUR -823.102%
Valerio Therapeutics Société anonyme 20.46 Million EUR 33.027%
DBV Technologies S.A. 38.74 Million USD 64.62%
Genfit S.A. 105.92 Million EUR 87.058%
GeNeuro SA 20.13 Million EUR 31.936%
Innate Pharma S.A. 132.29 Million EUR 89.638%
Inventiva S.A. 101.59 Million EUR 86.507%
MaaT Pharma SA 22.46 Million EUR 38.981%
MedinCell S.A. 77.77 Million EUR 82.374%
Nanobiotix S.A. 95.74 Million EUR 85.682%
OSE Immunotherapeutics SA 59.07 Million EUR 76.797%
Poxel S.A. 53.9 Million EUR 74.568%
GenSight Biologics S.A. 34.72 Million EUR 60.526%
Transgene SA 26.51 Million EUR 48.305%
Valneva SE 341.14 Million EUR 95.982%